These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 19461122

  • 1. A specific interleukin-1B haplotype correlates with high levels of IL1B mRNA in the lung and increased risk of non-small cell lung cancer.
    Landvik NE, Hart K, Skaug V, Stangeland LB, Haugen A, Zienolddiny S.
    Carcinogenesis; 2009 Jul; 30(7):1186-92. PubMed ID: 19461122
    [Abstract] [Full Text] [Related]

  • 2. Methyl-CpG binding domain 1 gene polymorphisms and risk of primary lung cancer.
    Jang JS, Lee SJ, Choi JE, Cha SI, Lee EB, Park TI, Kim CH, Lee WK, Kam S, Choi JY, Kang YM, Park RW, Kim IS, Cho YL, Jung TH, Han SB, Park JY.
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2474-80. PubMed ID: 16284366
    [Abstract] [Full Text] [Related]

  • 3. Vascular endothelial growth factor genotypes, haplotypes, gender, and the risk of non-small cell lung cancer.
    Zhai R, Liu G, Zhou W, Su L, Heist RS, Lynch TJ, Wain JC, Asomaning K, Lin X, Christiani DC.
    Clin Cancer Res; 2008 Jan 15; 14(2):612-7. PubMed ID: 18223238
    [Abstract] [Full Text] [Related]

  • 4. Association of IL-1B gene polymorphisms with nasopharyngeal carcinoma in a Chinese population.
    Zhu Y, Xu Y, Wei Y, Liang W, Liao M, Zhang L.
    Clin Oncol (R Coll Radiol); 2008 Apr 15; 20(3):207-11. PubMed ID: 18289837
    [Abstract] [Full Text] [Related]

  • 5. Interleukin 1 receptor antagonist gene polymorphism and risk of lung cancer: a possible interaction with polymorphisms in the interleukin 1 beta gene.
    Lind H, Zienolddiny S, Ryberg D, Skaug V, Phillips DH, Haugen A.
    Lung Cancer; 2005 Dec 15; 50(3):285-90. PubMed ID: 16126303
    [Abstract] [Full Text] [Related]

  • 6. Functional analysis of a lung cancer risk haplotype in the IL1B gene regulatory region.
    Landvik NE, Hart K, Haugen A, Zienolddiny S.
    J Hum Genet; 2012 Nov 26; 57(11):747-52. PubMed ID: 22951596
    [Abstract] [Full Text] [Related]

  • 7. Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China.
    Fang S, Jin X, Wang R, Li Y, Guo W, Wang N, Wang Y, Wen D, Wei L, Zhang J.
    Carcinogenesis; 2005 Feb 26; 26(2):481-6. PubMed ID: 15528217
    [Abstract] [Full Text] [Related]

  • 8. Interleukin-18 promoter polymorphism is associated with lung cancer: a case-control study.
    Farjadfar A, Mojtahedi Z, Ghayumi MA, Erfani N, Haghshenas MR, Ghaderi A.
    Acta Oncol; 2009 Feb 26; 48(7):971-6. PubMed ID: 19642044
    [Abstract] [Full Text] [Related]

  • 9. Haplotypes of nine single nucleotide polymorphisms on chromosome 19q13.2-3 associated with susceptibility of lung cancer in a Chinese population.
    Yin J, Vogel U, Ma Y, Qi R, Wang H.
    Mutat Res; 2008 May 10; 641(1-2):12-8. PubMed ID: 18358500
    [Abstract] [Full Text] [Related]

  • 10. Interleukin-1B (IL1B) and interleukin-6 (IL6) gene polymorphisms are associated with risk of chronic lymphocytic leukaemia.
    Ennas MG, Moore PS, Zucca M, Angelucci E, Cabras MG, Melis M, Gabbas A, Serpe R, Madeddu C, Scarpa A, Cocco P.
    Hematol Oncol; 2008 Jun 10; 26(2):98-103. PubMed ID: 18271063
    [Abstract] [Full Text] [Related]

  • 11. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.
    Park JY, Lee WK, Jung DK, Choi JE, Park TI, Lee EB, Cho S, Park JY, Cha SI, Kim CH, Kam S, Jung TH, Jheon S.
    Clin Cancer Res; 2009 Mar 01; 15(5):1794-800. PubMed ID: 19240174
    [Abstract] [Full Text] [Related]

  • 12. Haplotypes of IL1B, IL1RN, IL1R1, and IL1R2 and the risk of venous thrombosis.
    van Minkelen R, de Visser MC, Houwing-Duistermaat JJ, Vos HL, Bertina RM, Rosendaal FR.
    Arterioscler Thromb Vasc Biol; 2007 Jun 01; 27(6):1486-91. PubMed ID: 17413037
    [Abstract] [Full Text] [Related]

  • 13. Caspase 9 promoter polymorphisms and risk of primary lung cancer.
    Park JY, Park JM, Jang JS, Choi JE, Kim KM, Cha SI, Kim CH, Kang YM, Lee WK, Kam S, Park RW, Kim IS, Lee JT, Jung TH.
    Hum Mol Genet; 2006 Jun 15; 15(12):1963-71. PubMed ID: 16687442
    [Abstract] [Full Text] [Related]

  • 14. Polymorphisms in inflammatory pathway genes, host factors and lung cancer risk in Chinese female never-smokers.
    Lim WY, Chen Y, Ali SM, Chuah KL, Eng P, Leong SS, Lim E, Lim TK, Ng AW, Poh WT, Tee A, Teh M, Salim A, Seow A.
    Carcinogenesis; 2011 Apr 15; 32(4):522-9. PubMed ID: 21252117
    [Abstract] [Full Text] [Related]

  • 15. A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers.
    Zienolddiny S, Campa D, Lind H, Ryberg D, Skaug V, Stangeland LB, Canzian F, Haugen A.
    Carcinogenesis; 2008 Jun 15; 29(6):1164-9. PubMed ID: 18258609
    [Abstract] [Full Text] [Related]

  • 16. No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma.
    Wang Y, Fang S, Wei L, Wang R, Jin X, Wen D, Li Y, Guo W, Wang N, Zhang J.
    Lung Cancer; 2005 Aug 15; 49(2):155-61. PubMed ID: 15949868
    [Abstract] [Full Text] [Related]

  • 17. Molecular characterization of a cancer-related single nucleotide polymorphism in the pro-inflammatory interleukin-1B gene.
    Landvik NE, Tekpli X, Anmarkrud KH, Haugen A, Zienolddiny S.
    Mol Carcinog; 2012 Oct 15; 51 Suppl 1():E168-75. PubMed ID: 22467534
    [Abstract] [Full Text] [Related]

  • 18. DNMT3B polymorphisms and risk of primary lung cancer.
    Lee SJ, Jeon HS, Jang JS, Park SH, Lee GY, Lee BH, Kim CH, Kang YM, Lee WK, Kam S, Park RW, Kim IS, Cho YL, Jung TH, Park JY.
    Carcinogenesis; 2005 Feb 15; 26(2):403-9. PubMed ID: 15528220
    [Abstract] [Full Text] [Related]

  • 19. Polymorphisms in interleukin 1 beta and interleukin 1 receptor antagonist associated with tumor recurrence in stage II colon cancer.
    Lurje G, Hendifar AE, Schultheis AM, Pohl A, Husain H, Yang D, Manegold PC, Ning Y, Zhang W, Lenz HJ.
    Pharmacogenet Genomics; 2009 Feb 15; 19(2):95-102. PubMed ID: 18987561
    [Abstract] [Full Text] [Related]

  • 20. Functional haplotypes in the promoter of matrix metalloproteinase-2 and lung cancer susceptibility.
    Zhou Y, Yu C, Miao X, Wang Y, Tan W, Sun T, Zhang X, Xiong P, Lin D.
    Carcinogenesis; 2005 Jun 15; 26(6):1117-21. PubMed ID: 15731163
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.